NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

In Vitro Activity of Sulphonamides and Antiparasitic Agents against Cryptococcus neoformans (Cn).

AFELTRA J, VITALE RG, MEIS JF, VERWEIJ PE; Interscience Conference on Antimicrobial Agents and Chemotherapy (42nd : 2002 : San Diego, Calif.).

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 2002 Sep 27-30; 42: abstract no. M-1532.

Department of Medical Microbiology, University Medical Center, Nijmegen, Netherlands.

BACKGROUND: We investigated the in vitro activity of trimethoprim (TMP), pyrimethamine (PMT), 7 sulphonamides including sulphamethoxazole (SMX), cotrimoxazole (SXT), dapsone (DAP), sulfisoxazole (SSX), sulfamethizole (SMT), sulfadiazine (SDZ), sulphamethoxypyridazine (SMP), and 8 antiparasitic agents including chloroquine (CH), primaquine (PR), quinacrine (QR), quinine (QN), thiabendazole (TH), metronidazole (MT), artemisin (AR) and pentamidine (PN) against 42 clinical isolates of Cn. METHODS: Susceptibility testing was performed by broth microdilution method using two media (RPMI 1640 with 2%glucose and yeast nitrogen base [YNB] buffered with MOPS) incubated at 35 degrees C for 48 h with shaking. The inoculum size was 10[4] CFU/ml, and spectrophotometric determination of a 50% growth inhibition endpoint (MIC-2) was used. Final concentrations of the agents were 64 to 0.06 mg/l for TMP; 320 to 0.31 mg/l for SMT; 16/320 to 0.016/0.31 mg/l and 64/320 to 0.06/0.31 mg/l for SXT; 2 to 0.002 mg/l for PMT and PR; 8 to 0.008 mg/l for DAP; 640 to 0.62 mg/l for SMP; 320 to 0.31 mg/l for SSX, SMT and SDZ; 32 to 0.031 mg/l for CH, QN and PN; 16 to 0.21 mg/l for QR and AR; 128 to 0.12 for MT and TH. RESULTS: TMP, SSO, SMT, PMT, DAP, CH, PR, QR, QN, MT exhibited no activity in vitro. The MIC[50] of SMX, SXT, SDZ, SMP, TH were 80, 80, 320, 160, and 16 mg/l, respectively, in YNB and of AR and PN 4 and 1 mg/l, respectively, indicating in vitro activity. The antifungal activity was fungistatic. Sulphonamides were more active in YNB than in RPMI because RPMI contains high amounts of para-aminobenzoic acid which inhibits the activity of sulphonamides. PN and AR were more active in RPMI than YNB. CONCLUSIONS: SMX, SXT, SDZ, SMP, TH, AR and PN showed fungistatic antifungal activity against Cn, however more in vitro investigation, animal model and clinical trials are necessary to confirm these data.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Antifungal Agents
  • Antigens, Fungal
  • Antiparasitic Agents
  • Cryptococcosis
  • Cryptococcus neoformans
  • In Vitro
  • Microbial Sensitivity Tests
  • Sulfamethoxazole
  • Trimethoprim
  • immunology
Other ID:
  • GWAIDS0026912
UI: 102266536

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov